Clinical Trial Update: Tripterygium Wilfordii Hook F (TwHF) Treatment for Immune Non-responders With HIV-1 Infection [Phase 1, Phase 2]

View source ↗

Summary

This document provides a clinical trial update on using Tripterygium wilfordii Hook F (TwHF) to treat HIV-1 infection in immune non-responders, spanning Phase 1…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Tripterygium wilfordii Hook F (Tripterygium wilfordii Hook F)

Snippet

Sponsor: Beijing 302 Hospital | Conditions: Human Immunodeficiency Virus | Phase 1, Phase 2 | Status: UNKNOWN